Search
Telotristat ethyl
go.drugbank.com/drugs/DB12095Approved[L43367] Overexposure to serotonin can cause severe diarrhea, one of the main clinical symptoms of carcinoid syndrome. … [A252947] Neuroendocrine tumors (NET) arising from these cells can therefore secrete chemical mediators into the bloodstream to cause side effects in distant sites, a phenomenon called carcinoid syndrome
Categories: Cytochrome P-450 CYP2B6 Inducers, P-glycoprotein inhibitors105AD7
go.drugbank.com/drugs/DB05113Investigationalmetastatic colorectal cancer patients. 105AD7 may be a suitable vaccine for treatment of this disease. … 105AD7 is a human monoclonal antibody that mimics the complement regulatory protein, CD55, overexpressed by many solid tumours including osteosarcoma. 105AD7 induced antitumour inflammatory responses in
Cefmenoxime
go.drugbank.com/drugs/DB00267ApprovedCefmenoxime is a novel broad-spectrum and third-generation cephalosporin antibiotic that is typically used in the treatment of female gynecologic and obstetric infections. It is reported to exhibit high activity against a wide variety of...
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseTetrabenazine
go.drugbank.com/drugs/DB04844ApprovedA drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesPhenylethyl resorcinol
go.drugbank.com/drugs/DB14120ApprovedWithdrawnA tyrosinase inhibitor with skin-lightening activity.
Mixtures: I-max Lightening 5Nelfinavir
go.drugbank.com/drugs/DB00220ApprovedInvestigationalNelfinavir is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the...
Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseN-(2-Aminoethyl)-1-aziridineethanamine
go.drugbank.com/drugs/DB15643ExperimentalFirst described in the literature in 2004, N-(2-Aminoethyl)-1-aziridineethanamine is an experimental angiotensin converting enzyme 2 inhibitor investigated for its use in treating cardiovascular disease
PF-03654764
go.drugbank.com/drugs/DB12360InvestigationalPF-03654764 has been used in trials studying the basic science and treatment of Allergic Rhinitis.
Tepotinib
go.drugbank.com/drugs/DB15133ApprovedInvestigational[L31443,L31473] It is the first oral MET-targeted tyrosine kinase inhibitor to allow for once-daily dosing,[L31473] an advantage that may aid in easing the pill burden often associated with chemotherapeutic … In February 2022, tepotinib was approved for use in Europe.[L42200]
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesNeltenexine
go.drugbank.com/drugs/DB13239InvestigationalNeltenexine is an elastase inhibitor. It may be useful for preventing pulmonary emphysema.